he big type 1 diabetes foundation JDRF this week launched a new financial vehicle to more nimbly invest in companies developing medicines or devices for type 1 diabetes.

The JDRF T1D Fund, as the vehicle is being called, launches with $42 million and aims to raise $80 million in its first two years. The new fund will focus on opportunities toward the later stages of product development. It will often take equity stakes in companies, or negotiate a share of future product royalties.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine